Morphic Names Bruce Rogers as President of Morphic Therapeutic and Blaise Lippa as Chief Scientific Officer
WALTHAM, Mass., May 12, 2022 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
News
vTv Therapeutics Announces 2022 First Quarter Financial Results and Provides Corporate Update
HIGH POINT, N.C., May 12, 2022 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq:VTVT) today reported…
Akouos Reports First Quarter 2022 Financial Results and Provides Business Highlights
– Continued progress toward planned IND submissions for AK-OTOF in the first half of 2022…
Neuronetics Reports First Quarter 2022 Financial and Operating Results
MALVERN, Pa., May 12, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical…
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
Clinical programs for XTX202, a tumor-selective IL-2, and XTX101, a tumor-selective anti-CTLA-4, continue to advance…
Decibel Therapeutics Reports First Quarter 2022 Financial Results and Corporate Update
– Multiple milestones anticipated for 2022 including submission of IND and/or CTA for DB-OTO, top-line…
Wave Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
Delivered first clinical data demonstrating target engagement and translation of PN chemistry’s impact in clinic;…
Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual Meeting
SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated…
InflaRx Reports First Quarter 2022 Financial and Operating Results and Provides Strategic Update
Quarter highlighted by progress with vilobelimab in several indications: Encouraging Phase III topline results reported…
BridgeBio Announces Exclusive License Agreement with Bristol Myers Squibb to Develop and Commercialize BBP-398, a Potentially Best-in-Class SHP2 Inhibitor, in Oncology
– BridgeBio is eligible to receive up to $905 million, including an upfront payment of…
Aleafia Health Announces Agreement to Amend Convertible Debentures and Equity Financing of $5.6 Million
Transforms the company’s balance sheet with an equity financing to fund growth and a favourable…
Mindset Pharma Progresses Plans for Clinical Trials of its Advanced Pre-Clinical Psychedelic, MSP-1014
TORONTO, May 12, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Optinose Reports First Quarter 2022 Financial Results and Operational Updates
Company reports first quarter XHANCE net revenue of $14.8 million increased 35% compared to first…
TScan Therapeutics to Host Virtual KOL Event to Discuss its Solid Tumor Program Strategy and Highlights from the ASGCT 25th Annual Meeting
WALTHAM, Mass., May 12, 2022 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical…
Adagene to Participate in Investor Conferences in May and June
SAN DIEGO and SUZHOU, China, May 12, 2022 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq:…
Better Choice Company Reports Record First Quarter 2022 Gross Sales of $19.7 Million and Net Sales of $17.0 million, an Increase of 57% Year-Over-Year
NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE: BTTR) (the…
Entrada Therapeutics Reports First Quarter 2022 Financial Results
Second clinical candidate, ENTR-701, announced for the potential treatment of myotonic dystrophy type 1 On…
MediWound Announces Positive Results from Its U.S. Phase 2 Trial of EscharEx for Debridement of Chronic Wounds
Study Met Primary and Key Secondary Endpoints with Statistically Significant Results Compared to Control Arms Significant…
Save more with Verizon: Military, first responders, teachers and nurses get our best pricing
Qualifying customers can save up to $300 a year on our best 5G Unlimited plans…
Aptean 2022 Food and Beverage Symposium to Reveal Findings of New, Proprietary Industry Trends Research Study
Conference to Focus on Industry Strategies to Navigate Change and Celebrity Chef Insights Food &…